Concepedia

Yemi Olabiran

YO

Statistics

Publications

5

Citations

113

H-Index

5

Active since

1994

Affiliations

Royal London Hospital(Current)

University College London

Yemi Olabiran is an author at Royal London Hospital specializing in life sciences, immunoassay development, and immunoassay analysis.

Publications per year

1994–1999

5

Publications

5

Detection of the neural cell adhesion molecule (NCAM) in serum of patients with small-cell lung cancer (SCLC) with “limited” or “extensive” disease, and bone-marrow infiltration

JA Ledermann, Felice Pasini, Yemi Olabiran et al. · International Journal of Cancer · 1994 · 32 citations

Life Sciences, Cancer Biology, Oncology +14

Impact of antibody specificity and calibration material on the measure of agreement between methods for cardiac troponin I.

David Newman, Yemi Olabiran, William D. Bedzyk et al. · PubMed · 1999 · 28 citations

Life Sciences, Cardiology, Cardiac Nuclear Medicine +15

Impact of Antibody Specificity and Calibration Material on the Measure of Agreement between Methods for Cardiac Troponin I

David Newman, Yemi Olabiran, William D. Bedzyk et al. · Clinical Chemistry · 1999 · 27 citations · Full text

Life Sciences, Cardiology, Cardiac Nuclear Medicine +14

Development and validation of an automated latex-enhanced immunoassay for prealbumin

Peter Holownia, David Newman, Hansa Thakkar et al. · Clinical Chemistry · 1998 · 13 citations · Full text

Life Sciences, Biochemistry, Nutritional Sciences +15

The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodies

Yemi Olabiran, JA Ledermann, NJ Marston et al. · British Journal of Cancer · 1994 · 13 citations · Full text

Pharmacy, Cancer Biology, Oncology +17

1–5 of 5